Guo Edward Ming

Guo Edward Ming is a declared insider of Ascentage Pharma Group International, with filings sourced from SEC (Form 4). The record holds 18 filings, for trades running from 8 February 2021 to 19 May 2023.

Market trades split into 7 purchases (€189.3M) and 11 sales (€193.2M). The totals exclude 7 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2023, the count stands at 2 purchases and 1 sale.

The median purchase comes to €21k. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 29 September 2023 with an open-market purchase in Ascentage Pharma Group International. Filings reach the SEC (Form 4) feed a median of 5 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.